Studying immune cells in migraine blood
Part of Brain & nervous system clinical trials.
This study looks at blood samples from women with and without migraine to understand how certain immune cells (called regulatory T cells) might be involved. The goal is to learn more about what causes migraine, which could lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 50 years old.
- If you have chronic migraine, you have at least 8 migraine days per month.
- Your body mass index (BMI) is between 17 and 30.
- You do not have diabetes, autoimmune or inflammatory diseases, or immune system disorders.
- You are not pregnant, breastfeeding, or within 3 months of giving birth or miscarriage.
- You have not changed your migraine prevention medication within the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why headaches can become long-lasting (“chronified”) by combining answers from online questionnaires, brain imaging, and blood protein tests. Your participation may help researchers find biological clues that could improve how headache problems are understood and treated.
This study looks at how preventive treatments for severe migraines, like botulinum toxin injections or anti-CGRP antibody infusions, may affect thinking and quality of life. If you have frequent migraines that don't respond to other treatments, you might be able to join.
This study looks at how certain immune cells and inflammatory chemicals relate to migraines. If you have migraines or an autoimmune condition (like lupus, rheumatoid arthritis, or Crohn's disease), you may be able to participate. The goal is to understand what causes migraines.
This trial looks at whether anti-IL-6 treatments, already used for rheumatological conditions, can also help reduce migraines. If you have both a rheumatological condition and migraines, you might be able to join.
This study looks at blood samples from people with migraine to find proteins and other markers that might explain why migraines happen. The goal is to better understand migraine, which could help find better treatments in the future.
This study looks at the early signs that happen before a migraine starts, such as fatigue or mood changes. It aims to help people understand their migraine patterns better.
Hear when a new Chronic Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.